8月21日，施贵宝盘中上涨3.02%，报67.45美元/股，成交额1.58亿美元。
消息面上，施贵宝近日宣布与Chai Discovery达成抗体研发合作协议，将利用Chai的AI分子折叠与设计模型加速药物发现进程，探索传统方法难以触及的靶点。同时，制药板块整体表现强劲，默沙东涨3.47%、辉瑞涨2.21%、礼来涨1.93%、强生涨1.51%，板块联动效应显著。施贵宝前一交易日曾随板块回调跌逾3%，当前反弹亦受到技术性修复推动。
（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.